Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Aging (Albany NY) ; 8(3): 458-83, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26922388

RESUMEN

Suboptimal intake of dietary vitamin C (ascorbate) increases the risk of several chronic diseases but the exact metabolic pathways affected are still unknown. In this study, we examined the metabolic profile of mice lacking the enzyme gulonolactone oxidase (Gulo) required for the biosynthesis of ascorbate. Gulo-/- mice were supplemented with 0%, 0.01%, and 0.4% ascorbate (w/v) in drinking water and serum was collected for metabolite measurements by targeted mass spectrometry. We also quantified 42 serum cytokines and examined the levels of different stress markers in liver. The metabolic profiles of Gulo-/- mice treated with ascorbate were different from untreated Gulo-/- and normal wild type mice. The cytokine profiles of Gulo-/-mice, in return, overlapped the profile of wild type animals upon 0.01% or 0.4% vitamin C supplementation. The life span of Gulo-/- mice increased with the amount of ascorbate in drinking water. It also correlated significantly with the ratios of serum arginine/lysine, tyrosine/phenylalanine, and the ratio of specific species of saturated/unsaturated phosphatidylcholines. Finally, levels of hepatic phosphorylated endoplasmic reticulum associated stress markers IRE1α and eIF2α correlated inversely with serum ascorbate and life span suggesting that vitamin C modulates endoplasmic reticulum stress response and longevity in Gulo-/- mice.


Asunto(s)
Antioxidantes/administración & dosificación , Deficiencia de Ácido Ascórbico/sangre , Ácido Ascórbico/administración & dosificación , Longevidad/efectos de los fármacos , Metaboloma , Aminoácidos/sangre , Animales , Deficiencia de Ácido Ascórbico/tratamiento farmacológico , Peso Corporal/efectos de los fármacos , Citocinas/sangre , Proteínas de Unión al ADN/metabolismo , Estrés del Retículo Endoplásmico/efectos de los fármacos , Endorribonucleasas/metabolismo , Hormonas/sangre , L-Gulonolactona Oxidasa/genética , Masculino , Lípidos de la Membrana/sangre , Ratones , Ratones Noqueados , Mitocondrias Hepáticas/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/metabolismo , Factores de Transcripción/metabolismo
2.
FASEB J ; 24(1): 158-72, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19741171

RESUMEN

Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-like DNA helicase. Mice lacking the helicase domain of the WRN homologue exhibit many phenotypic features of WS, including a prooxidant status and a shorter mean life span compared to wild-type animals. Here, we show that Wrn mutant mice also develop premature liver sinusoidal endothelial defenestration along with inflammation and metabolic syndrome. Vitamin C supplementation rescued the shorter mean life span of Wrn mutant mice and reversed several age-related abnormalities in adipose tissues and liver endothelial defenestration, genomic integrity, and inflammatory status. At the molecular level, phosphorylation of age-related stress markers like Akt kinase-specific substrates and the transcription factor NF-kappaB, as well as protein kinase Cdelta and Hif-1alpha transcription factor levels, which are increased in the liver of Wrn mutants, were normalized by vitamin C. Vitamin C also increased the transcriptional regulator of lipid metabolism PPARalpha. Finally, microarray and gene set enrichment analyses on liver tissues revealed that vitamin C decreased genes normally up-regulated in human WS fibroblasts and cancers, and it increased genes involved in tissue injury response and adipocyte dedifferentiation in obese mice. Vitamin C did not have such effect on wild-type mice. These results indicate that vitamin C supplementation could be beneficial for patients with WS.


Asunto(s)
Envejecimiento/efectos de los fármacos , Ácido Ascórbico/uso terapéutico , Síndrome de Werner/tratamiento farmacológico , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/patología , Envejecimiento/genética , Envejecimiento/metabolismo , Animales , Secuencia de Bases , ADN Mitocondrial/genética , Modelos Animales de Enfermedad , Perfilación de la Expresión Génica , Glutatión/sangre , Glutatión/metabolismo , Humanos , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Longevidad/efectos de los fármacos , Longevidad/genética , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes , Microscopía Electrónica de Rastreo , Estrés Oxidativo , PPAR alfa/genética , RecQ Helicasas/genética , Síndrome de Werner/genética , Síndrome de Werner/metabolismo , Síndrome de Werner/patología , Helicasa del Síndrome de Werner
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA